Gabriel Rabinovich, senior group leader at the CaixaResearch Institute, has been awarded the 5th FERO Dr Baselga Grant. Promoted by FERO Cancer with the support of Fundación Gándara, the grant recognises research with transformative potential in oncology. 

The project will focus on developing new immunological strategies against pancreatic cancer, one of the most aggressive and difficult-to-treat cancers. More specifically, it will address pancreatic ductal adenocarcinoma and explore how the tumour microenvironment interferes with the immune system’s ability to respond effectively. 

Improving our understanding of these processes is essential to advancing more effective treatments. Through this project, Rabinovich and his team will investigate new ways to overcome some of the barriers that make pancreatic cancer especially challenging, helping to pave the way for future progress in this field. 

For us, this recognition highlights the international relevance of the research carried out at our institute and the potential of immunology to offer new answers to major health challenges. As Ángel Font, Executive Director of the CaixaResearch Institute, says, “This grant recognises a highly innovative line of research with enormous clinical potential. Gabriel Rabinovich’s work represents the kind of excellent, transformative science we aim to promote at the CaixaResearch Institute: research that expands fundamental knowledge while also bringing new solutions closer to patients.” 

This award also reinforces our commitment to immunology research that is closely connected to major biomedical challenges and real patient needs. At the CaixaResearch Institute, we work to better understand the role of the immune system in diseases such as cancer, infections and autoimmune disorders, and to help translate that knowledge into meaningful advances in human health.